BioXcel Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
BioXcel Therapeutics, Inc. (BTAI) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $167.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-13
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $167.00K.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $151.00K.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $354.00K.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.04M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2026-06-30 | $167.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $151.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $354.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.01M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.44M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $40.00K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $1.43M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $1.56M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $1.82M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $1.91M 10-K · filed 2026-03-27 |
| 2023-09-30 | $2.03M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $2.03M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $2.57M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $2.34M 10-K · filed 2025-03-28 |
| 2022-09-30 | $1.89M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.95M 10-Q · filed 2022-08-11 |
| 2021-12-31 | $1.95M 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |